RE: 200p by close of play today12 Feb 2021 14:44
£1,000 Margin per Treatment
200000 Treatments per month (Think the company have said 100,000 treatments per month may be able to up availability)
£2,400,000,000 Profit per annum (£1.2bn on 100,000 treatments)
6 PE Ratio (PE could be higher and up to 10???, However 6xPE sensible low?)
£18,000,000,000 Market Cap (£9bn mkt cap potential)
Shares in issue: 200m
£90.04 Target SP (£45.02)
To be fair, on the number of shares I have I would take £25 and run for the hills...lol
Plenty of upside here once P3 trials and US Activ-2 trials are concluded.
All the best....